Damage-Associated Molecular Patterns in Hypertension
Damage-Associated Molecular Patterns in Hypertension
批准号:
10094220
负责人:
Michael W. Brands
金额:
$188.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-02-01 至 2023-01-31
关键词:
Adaptive Immune SystemAddressAdultAgeAnimal ModelAnimalsApoptosisAutomobile DrivingBasic ScienceBehavioralBiologyBlood CirculationBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemCell AggregationCell DeathCellsCessation of lifeClinicalComplexDendritic CellsDevelopmentDisciplineDiseaseElementsEndothelial CellsErythrocytesEventExhibitsExperimental Animal ModelFemaleFoundationsGoalsHMGB1 ProteinHomeHumanHypertensionImmuneImmune systemImpairmentInbred SHR RatsInflammationInflammatoryInflammatory ResponseInjury to KidneyInnate Immune ResponseInnate Immune SystemInvestigationIschemiaKidneyKnowledgeLeadLinkMediator of activation proteinMetabolic stressMitochondriaMitochondrial DNAModelingMolecularMyelogenousNatriuresisNatural ImmunityNecrosisNeurosciencesNitric OxideOrganPathogenesisPathway interactionsPatternPattern RecognitionPattern recognition receptorPerfusionPericytesPeriodicityPeripheralPharmacologyPhenotypePhysiologicalPhysiologyPlayProductionReceptor ActivationRegulatory T-LymphocyteResearchResearch PersonnelRoleScientistSex DifferencesSignal TransductionT-Cell ActivationT-LymphocyteTLR4 geneTLR9 geneTestingTissuesToll-like receptorsVas OcclusionsVascular DiseasesVascular remodelingVasodilationadaptive immunityarterial stiffnessbaseblood pressure regulationcell injurycell typecollaborative approachdecubitus ulcerendothelial dysfunctionexperimental studyhypertension treatmentimprovedimproved outcomeinjuredinstrumentationinterdisciplinary approachmalemenmonocyteneutrophilnew therapeutic targetnovelorgan injuryprematurepressurepreventprogramssexsynergismtargeted treatmenttissue stresstooltranslational studytreatment groupvascular inflammationvascular injuryvasoconstrictionyoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROGRAM SUMMARY PROGRAM DIRECTOR, WEBB
The integrating theme and unifying hypothesis of this program project centers on the role played by damage-
associated-molecular patterns (DAMPs) in hypertension. DAMPs are alarm signals generated from injured
host cells, damaged tissues or metabolic stress and are recognized by the innate immune system. We
hypothesize that sustained activation of the innate immune system in hypertension is maladaptive, leading to
activation of circulating neutrophils and monocytes in the peripheral circulation, which home to the vasculature,
and cause increased tissue destruction and low-grade inflammation. These inflammatory events contribute to
increased vasoconstriction, vascular remodeling, and renal injury that occur under the action of initiating
factors to increase blood pressure. Project 1 will test the hypothesis that in hypertension, exaggerated
apoptosis and necrosis in the vascular wall give rise to mitochondrial DNA (mtDNA), a DAMP that activates
Toll-like receptor 9 (TLR9) causing vascular inflammation, vasoconstriction and endothelial dysfunction. In
Project 2, it is hypothesized that cell death induces high mobility group box 1 (HMGB1) release and TLR4
activation resulting in dentritic cell (DC) and T cell activation and increases in blood pressure in both sexes.
However, due to a sex difference in the type of cell death, the molecular pathway driving immune-based
hypertension in females favors greater T regulatory cell (Treg) formation. This hypothesis predicts that
necrosis results in greater HMGB1 release and TLR4 activation in males leading to myeloid DC activation of
Th17 cells and increases in blood pressure and end-organ damage relative to females, while greater apoptosis
in females limits HMGB1 release and activates plasmacytoid DC to increase Treg formation limiting increases
in blood pressure and injury relative to males. Project 3 tests the hypothesis that high circulating DAMPs
stimulate inappropriate nitric oxide (NO) production by vasa recta (VR) endothelial cells in low sheer states.
This NO production is detrimental as it inhibits spontaneous rhythmic contractions of VR pericytes that
normally act to prevent red blood cell aggregations under these conditions. RBC occlusion of the VR then
leads to rarefaction of the surrounding medullary vasculature, impaired pressure-natriuresis and hypertension.
These conceptually unique approaches, combined with novel technological tools will advance our
understanding of the molecular and physiological mechanisms underlying the initiation of vascular injury and
end organ damage of hypertension. All projects will use the spontaneously hypertensive rat as an animal
model. This highly integrative and collaborative approach of the three component projects is supported by an
Administrative Core (Core A), the Animal Use and Instrumentation Core (Core B) and the Bioinflammation
Core (Core C).
期刊论文(72)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.vph.2021.106861
发表时间:
2021-10
期刊:
Vascular pharmacology
影响因子:
4
作者:
[Dela Justina V, Giachini FR, Priviero F, Webb RC]
通讯作者:
Webb RC
Glutathione peroxidase 4 prevents 12/15 LOX induced renal oxidative cell death and improves renal post Ischemic recovery in Male Spontaneous Hypertensive Rats (SHR).
谷胱甘肽过氧化物酶 4 可防止 12/15 LOX 诱导的肾氧化细胞死亡并改善雄性自发性高血压大鼠 (SHR) 的肾缺血后恢复。
DOI:
--
发表时间:
2022
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Mohamed,Riyaz, Sullivan,JenniferC]
通讯作者:
Sullivan,JenniferC
DOI:
10.14814/phy2.15771
发表时间:
2023-08
期刊:
Physiological reports
影响因子:
2.5
作者:
[]
通讯作者:
DOI:
10.1152/ajpheart.00389.2018
发表时间:
2018-12-01
期刊:
American journal of physiology. Heart and circulatory physiology
影响因子:
--
作者:
[Taylor LE, Gillis EE, Musall JB, Baban B, Sullivan JC]
通讯作者:
Sullivan JC
DOI:
10.1042/cs20180368
发表时间:
2018-07-18
期刊:
Clinical science (London, England : 1979)
影响因子:
--
作者:
[Komic A, Martinez-Quinones P, McCarthy CG, Webb RC, Wenceslau CF]
通讯作者:
Wenceslau CF
共 39 条
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
-
批准号:10440320
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2020
-
负责人:Michael W. Brands
-
依托单位:
Pathophysiology of insulin-regulated renal blood flow and sodium excretion
-
批准号:10206134
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2020
-
负责人:Michael W. Brands
-
依托单位:
Animals and Instrumentation Core
-
批准号:10094226
-
项目类别:
-
资助金额:$29.34万
-
财政年份:2017
-
负责人:Michael W. Brands
-
依托单位:
Peach State Bridges to the Doctorate
-
批准号:9750021
-
项目类别:
-
资助金额:$20.82万
-
财政年份:2015
-
负责人:Michael W. Brands
-
依托单位:
Peach State Bridges to the Doctorate
-
批准号:8934722
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2015
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7433775
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2007
-
负责人:Michael W. Brands
-
依托单位:
Core--Animal
-
批准号:7433780
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2007
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:7228248
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2006
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7228243
-
项目类别:
-
资助金额:$16.91万
-
财政年份:2006
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:7063187
-
项目类别:
-
资助金额:$25.55万
-
财政年份:2005
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:7063182
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2005
-
负责人:Michael W. Brands
-
依托单位:
Il6 and Acute Pressor Response to Psychological Stress
-
批准号:6853166
-
项目类别:
-
资助金额:$16.14万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:7008871
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:6719792
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:6845400
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Core B- Animal Core
-
批准号:6853177
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
Renal Control of Blood Pressure in Early Diabetes
-
批准号:7173311
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2004
-
负责人:Michael W. Brands
-
依托单位:
CARDIOVASCULAR AND RENAL DYSFUNCTION IN EARLY DIABETES
-
批准号:6409618
-
项目类别:
-
资助金额:$6.27万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
Mechanisms for Cardiovascular Control Early in Diabetes
-
批准号:7037566
-
项目类别:
-
资助金额:$23.93万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
Mechanisms for Cardiovascular Control Early in Diabetes
-
批准号:7848811
-
项目类别:
-
资助金额:$33.08万
-
财政年份:1997
-
负责人:Michael W. Brands
-
依托单位:
海外基金